These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36082857)

  • 1. Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects.
    Shirbhate E; Patel VK; Tiwari P; Kore R; Veerasamy R; Mishra A; Rajak H
    Curr Top Med Chem; 2022; 22(22):1849-1867. PubMed ID: 36082857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Drug Therapy for the Management of Alzheimer's Disease.
    Kabir MT; Uddin MS; Mamun AA; Jeandet P; Aleya L; Mansouri RA; Ashraf GM; Mathew B; Bin-Jumah MN; Abdel-Daim MM
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic combinations for the treatment of Alzheimer's disease.
    Nagata T; Shinagawa S; Nakajima S; Noda Y; Mimura M
    Expert Opin Pharmacother; 2022 Apr; 23(6):727-737. PubMed ID: 35230200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
    Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
    Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
    J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
    Joe E; Ringman JM
    BMJ; 2019 Dec; 367():l6217. PubMed ID: 31810978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of Alzheimer's disease: where do we go from here?].
    Sellal F; Nieoullon A; Michel G; Michel BF; Lacomblez L; Geerts H; Delini-Stula A; Bentué-Ferrer D; Bordet R; Allain H
    Therapie; 2005; 60(2):89-107. PubMed ID: 15969312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for Alzheimer's disease in clinical trials.
    Godyń J; Jończyk J; Panek D; Malawska B
    Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimagining cholinergic therapy for Alzheimer's disease.
    Giacobini E; Cuello AC; Fisher A
    Brain; 2022 Jul; 145(7):2250-2275. PubMed ID: 35289363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets, trials and tribulations in Alzheimer therapeutics.
    Gharat R; Dixit G; Khambete M; Prabhu A
    Eur J Pharmacol; 2024 Jan; 962():176230. PubMed ID: 38042464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Alzheimer's disease: current status and new perspectives.
    Scarpini E; Scheltens P; Feldman H
    Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.
    Li J; Haj Ebrahimi A; Ali AB
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatments in Alzheimer's disease.
    Briggs R; Kennelly SP; O'Neill D
    Clin Med (Lond); 2016 Jun; 16(3):247-53. PubMed ID: 27251914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
    Herrmann N; Chau SA; Kircanski I; Lanctôt KL
    Drugs; 2011 Oct; 71(15):2031-65. PubMed ID: 21985169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in the Pharmacotherapy of Alzheimer's Disease.
    Khoury R; Patel K; Gold J; Hinds S; Grossberg GT
    Drugs Aging; 2017 Nov; 34(11):811-820. PubMed ID: 29116600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.